Evaluation of early progesterone use in high-risk women to prevent pre-term birth (PTB) predicted with a high level of Cervico-Vaginal Fluid (CVF) trappin2/elafin protein | ||||
| Minia Journal of Medical Research | ||||
| Article 57, Volume 30, Issue 4, October 2019, Page 356-359 PDF (176.23 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjmr.2022.221760 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Emad El-Din M. Salah; Amir ., A Abd Allah; Ahmed M. Abdel-Ghany; Amal O. Ali | ||||
| Department of Obstetrics and Gynecology, El-Minia Faculty of Medicine | ||||
| Abstract | ||||
| Introduction: Preterm birth is a global healthcare problem associated with significant neonatal morbidity and mortality and substantial healthcare costs. Aim of the work: Evaluate the role of early use of micronised vaginal progesterone at 14 weeks gestation in high risk women for SPTB predicted with high level of trappin2/elaffin protein in Cervico-Vaginal Fluid (CVF). Patients and Methods: This is a prospective study included 50 women who are 13 weeks of gestation and had high risk for preterm birth attend to obstetric clinic of Minia university hospital and Abo Korkas hospital during the period from November 2015 to December 2016. The study was approved by the faculty of medicine, Minia university ethical committee. Results: A total of 50 women who are 13 weeks of gestation and had high risk for preterm were included in this study. The results were presented as descriptive and analytical statistics and presented in tables. Conclusion: From the obtained results, it could be concluded that: To the best of our knowledge, very few work was done to study the relation between trappin2/elaffin protein cervical shortening and prediction of spontaneous preterm birth, so very little data is available about this topic. | ||||
| Keywords | ||||
| micronised vaginal progesterone; Cervico-Vaginal Fluid; | ||||
|
Supplementary Files
|
||||
|
Statistics Article View: 43 PDF Download: 103 |
||||
